SC 13G/A: Enveric Biosciences, Inc.

AI Summary

SC 13G/A filing by Enveric Biosciences, Inc..

Risk Assessment

Risk Level: low

FAQ

Key Financial Figures

• $0.01 — , Inc. (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securitie

Filing Documents

• sch13ga.htm (SC 13G/A) — 59KB
• 0000929638-24-003815.txt ( ) — 60KB

(a)

Item 1(a). Name of Issuer: Enveric Biosciences, Inc.

(b)

Item 1(b). Address of Issuer's Principal Executive Offices: 4851 Tamiami Trail N, Suite 200 Naples, Florida 34103

(a)

Item 2(a). Name of Person Filing: AdvisorShares Trust

(b)

Item 2(b). Address of Principal Business Office or, if none, Residence: 4800 Montgomery Lane, Suite 150 Bethesda, Maryland 20814

(c)

Item 2(c). Citizenship: Delaware

(d)

Item 2(d). Title of Class of Securities: Common Stock, $0.01 par value

(e)

Item 2(e). CUSIP Number: 29405E208 Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C 78o); (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C 78c); (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C 78c); (d) [ X ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J), please specify the type of institution: _______________ Page 3 of 5 Cusip No. 29405E208 Page 4 of 5 Pages Item 4. Provide the following information regarding the aggregate number and percentage of class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 367,047 (b) Percent of Class: 4.11% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 367,047 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 367,047 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. If this s

Certifications

Item 10. Certifications: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of its knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. November 12, 2024 (Date) /s/ Stefanie Little (Signature) Stefanie Little – Chief Compliance Officer Name and Title Page 5 of 5

View Full Filing

View this SC 13G/A filing on SEC EDGAR